- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ALK-positive NSCLC
Total 439486 results
-
Jacobio Pharmaceuticals Co., Ltd.AbbVieRecruitingNSCLC | Solid TumorUnited States
-
Jacobio Pharmaceuticals Co., Ltd.Active, not recruiting
-
Biodesix, Inc.CompletedNSCLC | Nodule Solitary PulmonaryUnited States
-
Beta Pharma, Inc.Completed
-
Jun Zhang, MD, PhDGenentech, Inc.; ExelixisNot yet recruitingLung Cancer | NSCLC Stage IV | Advanced NSCLC | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
EQRx, Inc.CompletedNSCLC | Healthy Volunteers | PharmacokineticsUnited States, New Zealand
-
Shanghai Chest HospitalUnknownNSCLC | SBRT | GM-CSFChina
-
ExelixisCompletedCancer | NSCLC | Solid TumorsJapan
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | Advanced Solid Tumor | CRCUnited States
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Shanghai Huaota Biopharmaceutical Co., Ltd.RecruitingNSCLC | Advanced Solid TumorUnited States, China
-
Niguarda HospitalUniversity of Turin, Italy; Fondazione del Piemonte per l'OncologiaCompleted
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
-
InventisBio Co., LtdMerck Sharp & Dohme LLCActive, not recruitingNSCLC | Solid Tumor, Adult | CRCUnited States, Taiwan, Australia, Korea, Republic of
-
The University of Hong KongUnknownNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIBHong Kong
-
Simcere Pharmaceutical Co., LtdUnknownAdvanced NSCLC | Recurrent NSCLCChina
-
Goethe UniversityRecruitingNSCLC Stage IV | NSCLC Stage IIIBGermany
-
Shanghai Pharmaceuticals Holding Co., LtdWithdrawn
-
Beijing Chest HospitalUnknown
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNSCLC | Advanced Cancer | Stage IV NSCLC | BRAF V600E Mutation | Stage IIIB NSCLC
-
Liaoning Tumor Hospital & InstituteNot yet recruitingNSCLC | EGF-R Positive Non-Small Cell Lung CancerChina
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
PfizerMerck Sharp & Dohme LLCTerminatedALK-positive Advanced NSCLCUnited States
-
Jun Zhang, MD, PhDUniversity of Iowa; University of KentuckyRecruitingNSCLC Stage IV | NSCLC Stage IIIBUnited States
-
Addario Lung Cancer Medical InstituteBiodesix, Inc.TerminatedNSCLC Stage IV | NSCLC, Stage IIICUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
Monte Rosa Therapeutics, IncRecruitingNSCLC | Prostate Cancer | SCLC | DLBCL | High Grade Neuroendocrine Cancer | L-MYC and N-MYC Amplified Solid Tumors | NSCLC With High or Low L-MYC or N-MYC Expression | HR-positive, HER2-negative Breast CancerUnited States, Canada
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR(+) NSCLC PatientsChina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR Mutated NSCLC.Taiwan
-
Shanghai Chest HospitalRecruitingNSCLC | NSCLC Stage IV | NSCLC, RecurrentChina
-
Jun Zhang, MD, PhDRecruitingNSCLC Stage IV | NSCLC, RecurrentUnited States
-
Maximilian DiehnAstraZenecaRecruitingNon Small Cell Lung Cancer | NSCLC, Stage III | NsclcUnited States
-
Fudan UniversityNot yet recruitingNSCLC Stage IV | NSCLC, RecurrentChina
-
University Hospital, EssenRecruitingNSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIABelgium, Germany, Netherlands
-
University of Kansas Medical Centerparkview cancer instituteRecruitingNSCLC Stage IV | NSCLC, RecurrentUnited States
-
Daping Hospital and the Research Institute of Surgery...CompletedNSCLC | Advanced Cancer | EGFR Gene Amplification | Stage IV NSCLC | Stage IIIB NSCLCChina
-
Guangdong Provincial People's HospitalRecruitingNSCLC, Stage I | Disease Free Survival | Pulmonary Function AssessmentChina
-
AIO-Studien-gGmbHAstraZenecaRecruitingNSCLC | EGFR Positive Non-small Cell Lung Cancer | OligoprogressionGermany
-
The Netherlands Cancer InstituteNot yet recruiting
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Peter MacCallum Cancer Centre, AustraliaRecruiting
-
University Hospital, MontpellierRecruiting
-
Shanghai Chest HospitalMerck Sharp & Dohme LLCRecruiting
-
Radboud University Medical CenterDutch Society of Physicians for Pulmonology and TuberculosisRecruiting
-
Lung Cancer Mutation ConsortiumLung Cancer Research FoundationRecruiting
-
Addario Lung Cancer Medical InstituteUniversity of Southern California; Ohio State University Comprehensive Cancer...Recruiting
-
Guangdong Association of Clinical TrialsRecruiting
-
EQRx International, Inc.Terminated